ZA200408202B - Process for synthesizing chiral N-aryl piperazines - Google Patents

Process for synthesizing chiral N-aryl piperazines Download PDF

Info

Publication number: ZA200408202B
Authority: ZA; South Africa
Prior art keywords: compound; formula; process according; group; amino
Prior art date: 2002-03-12

Application number

ZA200408202A

Other languages

English (en)

Inventor

Feigelson Gregg Brian

Jirkovsky Ivo

Zeldis Joseph

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-12

Filing date

2004-10-11

Publication date

2007-03-28

2004-10-11 Application filed by Wyeth Corp filed Critical Wyeth Corp

2007-03-28 Publication of ZA200408202B publication Critical patent/ZA200408202B/en

Links

238000000034 method Methods 0.000 title claims description 23
230000008569 process Effects 0.000 title claims description 20
230000002194 synthesizing effect Effects 0.000 title description 3
150000001875 compounds Chemical class 0.000 claims description 41
-1 2,3-dihydro-benzodioxin-5-yl Chemical group 0.000 claims description 27
125000000217 alkyl group Chemical group 0.000 claims description 11
125000003545 alkoxy group Chemical group 0.000 claims description 9
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 8
125000003118 aryl group Chemical group 0.000 claims description 8
229910052794 bromium Inorganic materials 0.000 claims description 5
229910052801 chlorine Inorganic materials 0.000 claims description 5
239000002585 base Substances 0.000 claims description 4
125000000000 cycloalkoxy group Chemical group 0.000 claims description 4
125000000753 cycloalkyl group Chemical group 0.000 claims description 4
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 4
SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 claims description 3
125000004432 carbon atom Chemical group C* 0.000 claims description 3
229910052736 halogen Inorganic materials 0.000 claims description 3
125000005843 halogen group Chemical group 0.000 claims description 3
150000002367 halogens Chemical class 0.000 claims description 3
125000001424 substituent group Chemical group 0.000 claims description 3
BKMMTJMQCTUHRP-GSVOUGTGSA-N (2r)-2-aminopropan-1-ol Chemical compound C[C@@H](N)CO BKMMTJMQCTUHRP-GSVOUGTGSA-N 0.000 claims description 2
239000002253 acid Substances 0.000 claims description 2
229910052783 alkali metal Inorganic materials 0.000 claims description 2
150000001340 alkali metals Chemical class 0.000 claims description 2
125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
125000003282 alkyl amino group Chemical group 0.000 claims description 2
239000000010 aprotic solvent Substances 0.000 claims description 2
125000004663 dialkyl amino group Chemical group 0.000 claims description 2
125000004982 dihaloalkyl group Chemical group 0.000 claims description 2
125000001188 haloalkyl group Chemical group 0.000 claims description 2
125000004970 halomethyl group Chemical group 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
150000002825 nitriles Chemical group 0.000 claims description 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
239000003880 polar aprotic solvent Substances 0.000 claims description 2
125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
125000004385 trihaloalkyl group Chemical group 0.000 claims description 2
125000004953 trihalomethyl group Chemical group 0.000 claims description 2
125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
125000005270 trialkylamine group Chemical group 0.000 claims 1
ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims 1
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 31
239000000243 solution Substances 0.000 description 19
235000019439 ethyl acetate Nutrition 0.000 description 14
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
239000003921 oil Substances 0.000 description 8
150000004885 piperazines Chemical class 0.000 description 8
239000011541 reaction mixture Substances 0.000 description 8
LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
238000006073 displacement reaction Methods 0.000 description 7
239000000203 mixture Substances 0.000 description 7
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
150000001412 amines Chemical class 0.000 description 6
GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 6
239000010410 layer Substances 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 5
238000004895 liquid chromatography mass spectrometry Methods 0.000 description 5
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 5
239000007787 solid Substances 0.000 description 5
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
230000029936 alkylation Effects 0.000 description 4
238000005804 alkylation reaction Methods 0.000 description 4
239000012267 brine Substances 0.000 description 4
239000000543 intermediate Substances 0.000 description 4
AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
239000012044 organic layer Substances 0.000 description 4
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
238000007363 ring formation reaction Methods 0.000 description 4
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 3
235000003351 Brassica cretica Nutrition 0.000 description 3
235000003343 Brassica rupestris Nutrition 0.000 description 3
241000219193 Brassicaceae Species 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
239000012359 Methanesulfonyl chloride Substances 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
238000001816 cooling Methods 0.000 description 3
125000004122 cyclic group Chemical group 0.000 description 3
150000005690 diesters Chemical class 0.000 description 3
150000002009 diols Chemical class 0.000 description 3
238000004128 high performance liquid chromatography Methods 0.000 description 3
125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
238000012544 monitoring process Methods 0.000 description 3
235000010460 mustard Nutrition 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
230000006340 racemization Effects 0.000 description 3
238000010992 reflux Methods 0.000 description 3
239000000741 silica gel Substances 0.000 description 3
229910002027 silica gel Inorganic materials 0.000 description 3
239000007858 starting material Substances 0.000 description 3
238000003756 stirring Methods 0.000 description 3
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
FIWILGQIZHDAQG-UHFFFAOYSA-N NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F Chemical compound NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F FIWILGQIZHDAQG-UHFFFAOYSA-N 0.000 description 2
239000002168 alkylating agent Substances 0.000 description 2
229940100198 alkylating agent Drugs 0.000 description 2
230000002152 alkylating effect Effects 0.000 description 2
WOBXIZDZSBFOEN-UHFFFAOYSA-N aniline 2,3-dihydro-1,4-benzodioxine Chemical compound NC1=CC=CC=C1.O1CCOC2=C1C=CC=C2 WOBXIZDZSBFOEN-UHFFFAOYSA-N 0.000 description 2
150000001450 anions Chemical class 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
239000010779 crude oil Substances 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
239000012452 mother liquor Substances 0.000 description 2
WGNFRNVIFIRYDD-UHFFFAOYSA-N n-[2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazin-1-yl]propyl]pyridin-2-amine Chemical compound C1CN(C=2C=3OCCOC=3C=CC=2)CCN1C(C)CNC1=CC=CC=N1 WGNFRNVIFIRYDD-UHFFFAOYSA-N 0.000 description 2
125000004193 piperazinyl group Chemical group 0.000 description 2
229910000027 potassium carbonate Inorganic materials 0.000 description 2
239000000047 product Substances 0.000 description 2
125000006239 protecting group Chemical group 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
230000009467 reduction Effects 0.000 description 2
MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 2
239000000725 suspension Substances 0.000 description 2
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
229940086542 triethylamine Drugs 0.000 description 2
XVHYFOJIWRBCAG-JTQLQIEISA-N (2S)-2-bromo-2-methyl-3-phenylpropanoic acid Chemical compound OC(=O)[C@](Br)(C)CC1=CC=CC=C1 XVHYFOJIWRBCAG-JTQLQIEISA-N 0.000 description 1
IQXXEPZFOOTTBA-UHFFFAOYSA-N 1-benzylpiperazine Chemical compound C=1C=CC=CC=1CN1CCNCC1 IQXXEPZFOOTTBA-UHFFFAOYSA-N 0.000 description 1
KJESGYZFVCIMDE-UHFFFAOYSA-N 1-chloroethanol Chemical compound CC(O)Cl KJESGYZFVCIMDE-UHFFFAOYSA-N 0.000 description 1
CGLZVQYQFQKYMF-UHFFFAOYSA-N 2,2-dichloro-n-(2,2-dichloroethyl)ethanamine Chemical compound ClC(Cl)CNCC(Cl)Cl CGLZVQYQFQKYMF-UHFFFAOYSA-N 0.000 description 1
DMLRSJNZORFCBD-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxin-5-amine Chemical compound O1CCOC2=C1C=CC=C2N DMLRSJNZORFCBD-UHFFFAOYSA-N 0.000 description 1
NWYYWIJOWOLJNR-UHFFFAOYSA-N 2-Amino-3-methyl-1-butanol Chemical compound CC(C)C(N)CO NWYYWIJOWOLJNR-UHFFFAOYSA-N 0.000 description 1
JCBPETKZIGVZRE-UHFFFAOYSA-N 2-aminobutan-1-ol Chemical compound CCC(N)CO JCBPETKZIGVZRE-UHFFFAOYSA-N 0.000 description 1
ULAXUFGARZZKTK-UHFFFAOYSA-N 2-aminopentan-1-ol Chemical compound CCCC(N)CO ULAXUFGARZZKTK-UHFFFAOYSA-N 0.000 description 1
VVRVZXIIKFLHIH-DFWYDOINSA-N 2-aminopropan-1-ol (2S)-2-aminopropan-1-ol Chemical compound CC(N)CO.C[C@H](N)CO VVRVZXIIKFLHIH-DFWYDOINSA-N 0.000 description 1
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
USEDMAWWQDFMFY-UHFFFAOYSA-N 4-cyanobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(C#N)C=C1 USEDMAWWQDFMFY-UHFFFAOYSA-N 0.000 description 1
108091032151 5-hydroxytryptamine receptor family Proteins 0.000 description 1
RLMOJWSWKVTSJT-UHFFFAOYSA-M 6-(2,3-dihydro-1,4-benzodioxin-5-yl)-2-methyl-6-aza-3-azoniaspiro[2.5]octane;chloride Chemical compound [Cl-].CC1C[N+]11CCN(C=2C=3OCCOC=3C=CC=2)CC1 RLMOJWSWKVTSJT-UHFFFAOYSA-M 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
102000014630 G protein-coupled serotonin receptor activity proteins Human genes 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
125000002252 acyl group Chemical group 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
125000003158 alcohol group Chemical group 0.000 description 1
150000001335 aliphatic alkanes Chemical class 0.000 description 1
125000005257 alkyl acyl group Chemical group 0.000 description 1
150000003973 alkyl amines Chemical class 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
150000003927 aminopyridines Chemical class 0.000 description 1
150000001448 anilines Chemical class 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
150000003939 benzylamines Chemical class 0.000 description 1
150000001649 bromium compounds Chemical class 0.000 description 1
125000001246 bromo group Chemical group Br* 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
229910052792 caesium Inorganic materials 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
239000003610 charcoal Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000012043 crude product Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
125000000062 cyclohexylmethoxy group Chemical group [H]C([H])(O*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
125000006371 dihalo methyl group Chemical group 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000012458 free base Substances 0.000 description 1
238000007306 functionalization reaction Methods 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
239000000463 material Substances 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
238000007040 multi-step synthesis reaction Methods 0.000 description 1
239000012074 organic phase Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
235000015320 potassium carbonate Nutrition 0.000 description 1
235000011181 potassium carbonates Nutrition 0.000 description 1
150000003138 primary alcohols Chemical class 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
150000003335 secondary amines Chemical class 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
239000002002 slurry Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
235000014347 soups Nutrition 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

ZA200408202A 2002-03-12 2004-10-11 Process for synthesizing chiral N-aryl piperazines ZA200408202B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US36343102P	2002-03-12	2002-03-12

Publications (1)

Publication Number	Publication Date
ZA200408202B true ZA200408202B (en)	2007-03-28

Family

ID=28041762

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200408202A ZA200408202B (en)	2002-03-12	2004-10-11	Process for synthesizing chiral N-aryl piperazines

Country Status (23)

Country	Link
US (1)	US6713626B2 (de)
EP (1)	EP1483255B1 (de)
JP (1)	JP4391241B2 (de)
KR (1)	KR20040105765A (de)
CN (2)	CN1304388C (de)
AR (1)	AR038930A1 (de)
AT (1)	ATE439356T1 (de)
AU (1)	AU2003220094B2 (de)
BR (1)	BR0308377A (de)
CA (1)	CA2477892C (de)
CR (1)	CR7431A (de)
DE (1)	DE60328756D1 (de)
EC (1)	ECSP045290A (de)
ES (1)	ES2329122T3 (de)
IL (1)	IL163827A0 (de)
MX (1)	MXPA04008729A (de)
NO (1)	NO20044050L (de)
NZ (1)	NZ535168A (de)
RU (1)	RU2315762C2 (de)
TW (1)	TW200403231A (de)
UA (1)	UA79273C2 (de)
WO (1)	WO2003078417A1 (de)
ZA (1)	ZA200408202B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060287335A1 (en) *	2000-11-28	2006-12-21	Wyeth	Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en)	2000-11-28	2006-10-05	Wyeth	Serotonergic agents
US7504395B2 (en) *	2001-07-20	2009-03-17	Psychogenics, Inc.	Treatment for attention-deficit hyperactivity disorder
ATE360002T1 (de) *	2002-03-12	2007-05-15	Wyeth Corp	Verfahren zur herstellung von n1-(2'-pyridyl)-1,2-propandiaminsulfamidsäure und ihre verwendung zur herstellung von biologisch aktiven piperazinen
US7361773B2 (en)	2002-03-12	2008-04-22	Wyeth	Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
US7091349B2 (en) *	2002-03-12	2006-08-15	Wyeth	Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
MXPA04008730A (es) *	2002-03-12	2004-12-06	Wyeth Corp	Proceso para preparacion de piperazinas quirales 1,4-disustituidas.
US20050215561A1 (en) *	2004-03-19	2005-09-29	Krishnendu Ghosh	Pharmaceutical dosage forms and compositions
US20070099931A1 (en) *	2004-03-19	2007-05-03	Wyeth	Pharmaceutical dosage forms and compositions
US20050209245A1 (en) *	2004-03-19	2005-09-22	Wyeth	Process for preparing N-aryl-piperazine derivatives
CN101137648A (zh) *	2005-03-01	2008-03-05	惠氏公司	结晶和非晶4－氰基－n－{(2r)－2－[4－(2,3－二氢－苯并[1,4]二氧杂环己烯－5－基)－哌嗪－1－基]－丙基}－n－吡啶－2－基－苯甲酰胺盐酸盐
CN117003693B (zh) *	2022-05-05	2026-01-30	四川大学华西医院	一类哌啶衍生物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3586794T2 (de)	1984-12-21	1993-05-27	Duphar Int Res	Arzneimittel mit psychotroper wirkung.
JPH01125357A (ja)	1987-11-06	1989-05-17	Dainippon Pharmaceut Co Ltd	トリペプチドの誘導体
IL101722A (en) *	1991-05-02	1996-05-14	Wyeth John & Brother Ltd	Piperazine derivatives their preparation and pharmaceutical compositions containing them
GB9125900D0 (en) *	1991-12-05	1992-02-05	Wyeth John & Brother Ltd	Piperazine derivatives
WO1994024115A1 (fr)	1993-04-16	1994-10-27	Santen Pharmaceutical Co., Ltd.	Nouveau derive de piperazine
GB9411099D0 (en) *	1994-06-03	1994-07-27	Wyeth John & Brother Ltd	Piperazine derivatives
EP0763024B1 (de)	1994-06-03	2002-08-14	JOHN WYETH & BROTHER LIMITED	Verfahren und zwischenprodukte zur herstellung von piperazinderivaten
GB9413772D0 (en) *	1994-07-08	1994-08-24	Wyeth John & Brother Ltd	5-HT1A ligands
GB9514901D0 (en) *	1995-07-20	1995-09-20	American Home Prod	Piperazine derivatives
CA2251017A1 (en)	1996-04-10	1997-10-16	Mark E. Duggan	.alpha.v.beta.3 antagonists
US6469007B2 (en)	2000-11-28	2002-10-22	Wyeth	Serotonergic agents

2003
- 2003-03-10 AT AT03716384T patent/ATE439356T1/de not_active IP Right Cessation
- 2003-03-10 AU AU2003220094A patent/AU2003220094B2/en not_active Expired - Fee Related
- 2003-03-10 BR BR0308377-2A patent/BR0308377A/pt not_active IP Right Cessation
- 2003-03-10 WO PCT/US2003/007078 patent/WO2003078417A1/en not_active Ceased
- 2003-03-10 MX MXPA04008729A patent/MXPA04008729A/es active IP Right Grant
- 2003-03-10 TW TW092105097A patent/TW200403231A/zh unknown
- 2003-03-10 NZ NZ535168A patent/NZ535168A/xx unknown
- 2003-03-10 CN CNB038058413A patent/CN1304388C/zh not_active Expired - Fee Related
- 2003-03-10 ES ES03716384T patent/ES2329122T3/es not_active Expired - Lifetime
- 2003-03-10 JP JP2003576423A patent/JP4391241B2/ja not_active Expired - Fee Related
- 2003-03-10 EP EP03716384A patent/EP1483255B1/de not_active Expired - Lifetime
- 2003-03-10 CN CNA2007100083292A patent/CN1982307A/zh active Pending
- 2003-03-10 IL IL16382703A patent/IL163827A0/xx unknown
- 2003-03-10 KR KR10-2004-7014156A patent/KR20040105765A/ko not_active Ceased
- 2003-03-10 CA CA2477892A patent/CA2477892C/en not_active Expired - Fee Related
- 2003-03-10 RU RU2004130300/04A patent/RU2315762C2/ru not_active IP Right Cessation
- 2003-03-10 DE DE60328756T patent/DE60328756D1/de not_active Expired - Lifetime
- 2003-03-10 US US10/384,845 patent/US6713626B2/en not_active Expired - Fee Related
- 2003-03-11 AR ARP030100831A patent/AR038930A1/es unknown
- 2003-10-03 UA UA20041008211A patent/UA79273C2/uk unknown
2004
- 2004-08-24 CR CR7431A patent/CR7431A/es not_active Application Discontinuation
- 2004-09-10 EC EC2004005290A patent/ECSP045290A/es unknown
- 2004-09-24 NO NO20044050A patent/NO20044050L/no not_active Application Discontinuation
- 2004-10-11 ZA ZA200408202A patent/ZA200408202B/en unknown

Also Published As

Publication number	Publication date
CN1642936A (zh)	2005-07-20
ATE439356T1 (de)	2009-08-15
WO2003078417A1 (en)	2003-09-25
AU2003220094A1 (en)	2003-09-29
CR7431A (es)	2008-07-29
BR0308377A (pt)	2005-01-11
RU2004130300A (ru)	2005-04-10
KR20040105765A (ko)	2004-12-16
DE60328756D1 (de)	2009-09-24
ECSP045290A (es)	2004-10-26
CA2477892C (en)	2010-11-23
IL163827A0 (en)	2005-12-18
CA2477892A1 (en)	2003-09-25
NZ535168A (en)	2006-03-31
CN1304388C (zh)	2007-03-14
US6713626B2 (en)	2004-03-30
EP1483255A1 (de)	2004-12-08
RU2315762C2 (ru)	2008-01-27
JP4391241B2 (ja)	2009-12-24
CN1982307A (zh)	2007-06-20
JP2005526775A (ja)	2005-09-08
ES2329122T3 (es)	2009-11-23
AU2003220094B2 (en)	2009-04-23
NO20044050L (no)	2004-09-24
TW200403231A (en)	2004-03-01
MXPA04008729A (es)	2005-07-13
EP1483255B1 (de)	2009-08-12
UA79273C2 (en)	2007-06-11
AR038930A1 (es)	2005-02-02
US20030187265A1 (en)	2003-10-02

Publication	Publication Date	Title
EP0633260B1 (de)	2001-11-07	2,3-Dihydro-1,4-Benzodioxan-5-yl-piperazinderivate als 5-HT1A-Antagonisten
JP2024023340A (ja)	2024-02-21	グルホシネートアンモニウムの調製方法
US6713626B2 (en)	2004-03-30	Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
EP1801103B1 (de)	2009-11-18	Verfahren zur Herstellung von n1-(2-pyridyl)-1,2-Propandiaminsulfamidsäure und ihre Verwendung zur Herstellung von biologisch aktiven Piperazinen
FI91064C (fi)	1994-05-10	Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi
US20040230056A1 (en)	2004-11-18	Process for synthesizing N-aryl piperazines with chiral N'-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
US7256289B2 (en)	2007-08-14	Process for making chiral 1,4-disubstituted piperazines
JP2006225391A (ja)	2006-08-31	トルテロジンの調製方法
PL182914B1 (pl)	2002-04-30	Sposób wytwarzania (-)-N-metylo-N-[4-(4-fenylo-4-acetyloaminopiperydyn-1-ylo)-2-(3,4-dichlorofenylo)butylo]benzamidu
HK1104816A (en)	2008-01-25	Preparation of 2-((2,3- dihydro-benzo(1,4) dioxin-5-yl)-(2-hydroxyethyl)-amino)-ethanol and related intermediates
KR20040086305A (ko)	2004-10-08	에틸 2,3-디히드로벤조[1,4]디옥신-2-카르복실레이트의제조방법